• Mayne Pharma Launches Lexette Foam 0.05% in the US americanpharmaceuticalreview
    February 15, 2019
    Mayne Pharma has announced the launch of LEXETTE (halobetasol propionate) Foam 0.05% in the United States. LEXETTE, the conditionally-acceptable trade name for halobetasol foam is a new formulation of halobetasol...
PharmaSources Customer Service